Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home Care Setting) - Global Forecast to 2020

Publisher Name :
Date: 24-Aug-2015
No. of pages: 241
Inquire Before Buying

The injectable drug delivery market is expected to reach $547.8 billion by 2020 from $326.1 billion in 2015, growing at a CAGR of 12.0% from 2015 to 2020. The market is categorized on the basis of type, therapeutic application, usage pattern, mode of administration, end user, and region. The therapeutic application market is further segmented into autoimmune diseases, hormonal disorders, oncology, orphan diseases, and other therapeutic applications. The oncology segment is expected to witness the highest CAGR in the forecast period.

Factors such as rising incidences of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements, are driving the growth of the injectable drug delivery market. In addition, emphasis on innovation of formulations and improving the delivery of pharmaceuticals is also contributing to the growth of the market. For instance, in November 2012, COMPACT (Collaboration on the Optimization of Macromolecular Pharmaceutical Access to Cellular Targets), a public-private consortium funded by the Innovative Medicines Initiative (IMI), announced the launch of a €30 million ($38.5 million) project, which focuses on improving the delivery of biopharmaceuticals. The consortium would address the major bottlenecks in the development of novel innovative medicines based on biological macromolecules, such as proteins/peptides and oligonucleotides. Such investments are fueling the growth of the market.

Asia is expected to be the fastest-growing country in the injectable drug delivery market. High growth in this market can be attributed to the increased demand for injectable insulin and self-injection devices, particularly pen injectors which are used in the treatment of diabetes.

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the injectable drug delivery market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:


  • Market Penetration: Comprehensive information on the product portfolios of the top players in the injectable drug delivery market. The report analyzes this market by type, therapeutic application, usage pattern, mode of administration, end user, and region

  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the injectable drug delivery market

  • Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the injectable drug delivery market

  • Market Development: Comprehensive information about lucrative markets. The report analyzes the market for various injectable drug delivery across countries

  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the injectable drug delivery market

Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home Care Setting) - Global Forecast to 2020

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Market Stakeholders

2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Key Data From Secondary Sources
2.4 Key Data From Primary Sources
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Injectable Drug Delivery Market, By Formulation
4.2 Injectable Drug Delivery Market, By Usage Pattern
4.3 Injectable Drug Delivery Market, By Mode of Administration
4.4 Injectable Drug Delivery Market, By Therapeutic Application
4.5 Geographical Snapshot

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.2.1 By Type
5.2.2 By Therapeutic Application
5.2.3 By Usage Pattern
5.2.4 By Mode of Administration
5.2.5 By End User
5.2.6 By Region
5.3 Market Dynamics
5.4 Drivers
5.4.1 Rising Prevalence of Chronic Diseases
5.4.2 Increase in Demand for Self-Injection Devices
5.4.3 Growth of the Biologics Market
5.4.4 Technological Advancements
5.5 Restraints
5.5.1 Needlestick Injuries and Infections
5.6 Opportunities
5.6.1 Increase in Demand for Biosimilars and Generic Injectables
5.6.1.1 Biosimilars
5.6.1.2 Generic Injectables
5.6.2 Contraceptive Injectables
5.7 Challenges
5.7.1 Product Recalls
5.7.2 Regulatory Hurdles
5.7.3 Stability of Products
5.7.4 Sterility of Injections
5.7.5 Preference for Other Modes of Drug Delivery

6 Injectable Drug Delivery Market, By Type
6.1 Introduction
6.2 Devices
6.2.1 Conventional Injection Devices
6.2.1.1 By Material
6.2.1.1.1 Glass
6.2.1.1.2 Plastic
6.2.1.2 By Product
6.2.1.2.1 Fillable Syringes
6.2.1.2.2 Prefilled Syringes
6.2.1.3 By Usability
6.2.1.3.1 Reusable Syringes
6.2.1.3.2 Disposable Syringes
6.2.2 Self-Injection Devices
6.2.2.1 Needle-Free Injectors
6.2.2.1.1 By Product
6.2.2.1.1.1 Fillable Needle-Free Injectors
6.2.2.1.1.2 Prefilled Needle-Free Injectors
6.2.2.1.2 By Technology
6.2.2.1.2.1 Jet-Based Needle-Free Injectors
6.2.2.1.2.2 Spring-Based Needle-Free Injectors
6.2.2.1.2.3 Laser-Powered Needle-Free Injectors
6.2.2.1.2.4 Vibration-Based Needle-Free Injectors
6.2.2.1.3 By Usability
6.2.2.1.3.1 Reusable Needle-Free Injectors
6.2.2.1.3.2 Disposable Needle-Free Injectors
6.2.2.2 Autoinjectors
6.2.2.2.1 By Product
6.2.2.2.1.1 Fillable Autoinjectors
6.2.2.2.1.2 Prefilled Autoinjectors
6.2.2.2.2 By Technology
6.2.2.2.2.1 Automated Autoinjectors
6.2.2.2.2.2 Manual Autoinjectors
6.2.2.2.3 By Design
6.2.2.2.3.1 Standardized Autoinjectors
6.2.2.2.3.2 Customized Autoinjectors
6.2.2.2.4 By Usability
6.2.2.2.4.1 Reusable Autoinjectors
6.2.2.2.4.2 Disposable Autoinjectors
6.2.2.3 Pen Injectors
6.2.2.3.1 By Product
6.2.2.3.1.1 Single-Chambered Pen Injectors
6.2.2.3.1.2 Dual-Chambered Pen Injectors
6.2.2.3.2 By Design
6.2.2.3.2.1 Standard Pen Injectors
6.2.2.3.2.2 Customized Pen Injectors
6.2.2.3.3 By Usability
6.2.2.3.3.1 Reusable Pen Injectors
6.2.2.3.3.2 Disposable Pen Injectors
6.2.2.4 Wearable Injectors
6.2.2.5 Other Devices
6.3 Formulations
6.3.1 Conventional Drug Delivery
6.3.1.1 Solutions
6.3.1.2 Reconstituted/Lyophilized Formulations
6.3.1.3 Suspensions
6.3.1.4 Emulsions
6.3.2 Novel Drug Delivery Formulations
6.3.2.1 Colloidal Dispersions
6.3.2.1.1 Liposomes
6.3.2.1.2 Niosomes
6.3.2.1.3 Polymeric/Mixed Micelles
6.3.2.1.4 Nanoparticles
6.3.2.1.4.1 Nanosuspensions
6.3.2.1.4.2 Nanoemulsions/Microemulsions
6.3.2.1.4.3 Solid-Lipid Nanoparticles
6.3.2.2 Microparticles
6.3.2.2.1 Microspheres
6.3.2.2.2 Microcapsules
6.3.3 Long-Acting Injection Formulations

7 Injectable Drug Delivery Market, By Therapeutic Application
7.1 Introduction
7.2 Autoimmune Diseases
7.2.1 Rheumatoid Arthritis
7.2.2 Multiple Sclerosis
7.2.3 Crohn’s Disease
7.2.4 Psoriasis
7.2.5 Other Autoimmune Diseases
7.3 Hormonal Disorders
7.3.1 Diabetes
7.3.2 Anemia
7.3.3 Reproductive Health Disease
7.3.4 Antithrombotic/Thrombolytic Therapy
7.3.5 Osteoporosis
7.3.6 Growth Hormone Deficiency (GHD)
7.4 Orphan Diseases
7.5 Oncology
7.6 Others
7.6.1 Pain Management
7.6.2 Allergy Treatment
7.6.3 Aesthetic Treatments
7.6.4 Hepatitis C
7.6.5 Hemophilia

8 Injectable Drug Delivery Market, By Usage Pattern
8.1 Introduction
8.2 Curative Care
8.3 Immunization
8.4 Other Usage Patterns (Blood Transfusion and Blood Products, and Contraceptives)

9 Injectable Drug Delivery Market, By Mode of Administration
9.1 Introduction
9.2 Skin
9.3 Circulatory/Musculoskeletal
9.4 Organs
9.5 Central Nervous System

10 Injectable Drug Delivery Market, By End User
10.1 Introduction
10.2 Hospitals and Clinics
10.3 Home Care Settings
10.4 Research Laboratories
10.5 Pharmaceutical and Biotechnology Companies
10.6 Other End Users

11 Injectable Drug Delivery Market, By Region
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 U.K.
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe (RoE)
11.4 Asia
11.5 Rest of the World (RoW)

12 Competitive Landscape
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Situations & Trends
12.3.1 New Product Launches
12.3.2 FDA Approvals
12.3.3 Expansions and Investments
12.3.4 Acquisitions
12.3.5 Collaborations

13 Company Profiles
13.1 Introduction
13.2 Baxter International, Inc.
13.2.1 Business Overview
13.2.2 Product Offerings
13.2.3 Recent Developments
13.2.4 MnM View
13.3 Becton, Dickinson and Company
13.3.1 Business Overview
13.3.2 Product Offerings
13.3.3 Recent Developments
13.3.4 MnM View
13.4 Gerresheimer AG
13.4.1 Business Overview
13.4.2 Products Offered
13.4.3 Recent Developments
13.4.4 MnM View
13.5 Pfizer, Inc.
13.5.1 Business Overview
13.5.2 Products Offered
13.5.3 Recent Developments
13.5.4 MnM View
13.6 Schott AG
13.6.1 Business Overview
13.6.2 Product Offerings
13.6.3 Recent Developments
13.6.4 MnM View
13.7 Alkermes PLC
13.7.1 Business Overview
13.7.2 Products Offered
13.7.3 Recent Developments
13.8 ELI Lilly and Company
13.8.1 Business Overview
13.8.2 Products Offered
13.8.3 Recent Developments
13.9 Sandoz
13.9.1 Business Overview
13.9.2 Products Offered
13.9.3 Recent Developments
13.10 Terumo Corporation
13.10.1 Business Overview
13.10.2 Products Offered
13.10.3 Recent Developments
13.11 Teva Pharmaceutical Industries Ltd.
13.11.1 Business Overview
13.11.2 Product Offerings
13.11.3 Recent Developments

14 Appendix
14.1 Insights From Industry Experts
14.2 Discussion Guide
14.3 Other Recent Developments
14.4 Available Customizations
14.5 RT: Real-Time Market Intelligence
14.6 Related Reports

List of Tables

Table 1 Examples of Technological Advancements (2013–2015)
Table 2 Rising Prevalence of Chronic Diseases Across the Globe is A Major Factor Driving Market Growth
Table 3 Needlestick Injuries and Infections are Major Factors Limiting the Growth of the Market
Table 4 Increase in Demand for Biosimilars Offers an Array of Opportunities for the Market
Table 5 Examples of Product Recalls (2010–2015)
Table 6 Product Recalls are A Significant Challenge for Market Growth
Table 7 Injectable Drug Delivery Market Size, By Type, 2013–2020 (USD Million)
Table 8 Injectable Drug Delivery Market Size, By Region, 2013–2020 (USD Million)
Table 9 Injectable Drug Delivery Devices Market Size, By Type, 2013–2020 (USD Million)
Table 10 Injectable Drug Delivery Devices Market Size, By Region, 2013–2020 (USD Million)
Table 11 Conventional Injection Devices Market Size, By Region, 2013–2020 (USD Million)
Table 12 Conventional Injection Devices Market Size, By Material, 2013–2020 (USD Million)
Table 13 Conventional Glass Injection Devices Market Size, By Region, 2013–2020 (USD Million)
Table 14 Conventional Plastic Injection Devices Market Size, By Region, 2013–2020 (USD Million)
Table 15 Conventional Injection Devices Market Size, By Product, 2013–2020 (USD Million)
Table 16 Conventional Fillable Injection Devices Market Size, By Region, 2013–2020 (USD Million)
Table 17 Conventional Prefilled Injection Devices Market Size, By Region,  2013–2020 (USD Million)
Table 18 Conventional Injection Devices Market Size, By Usability, 2013–2020 (USD Million)
Table 19 Conventional Reusable Injection Devices Market Size, By Region, 2013–2020 (USD Million)
Table 20 Conventional Disposable Injection Devices Market Size, By Region,  2013–2020 (USD Million)
Table 21 Self-Injection Devices Market Size, By Type, 2013–2020 (USD Million)
Table 22 Self-Injection Devices Market Size, By Region, 2013–2020 (USD Million)
Table 23 Needle-Free Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 24 Needle-Free Injectors Market Size, By Product, 2013–2020 (USD Million)
Table 25 Fillable Needle-Free Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 26 Prefilled Needle-Free Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 27 Needle-Free Injectors Market Size, By Technology, 2013–2020 (USD Million)
Table 28 Jet-Based Needle-Free Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 29 Spring-Based Needle-Free Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 30 Laser-Powered Needle-Free Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 31 Vibration-Based Needle-Free Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 32 Needle-Free Injectors Market Size, By Usability, 2013–2020 (USD Million)
Table 33 Reusable Needle-Free Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 34 Disposable Needle-Free Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 35 Autoinjector Devices Market Size, By Region, 2013–2020 (USD Million)
Table 36 Autoinjector Devices Market Size, By Product, 2013–2020 (USD Million)
Table 37 Fillable Autoinjector Devices Market Size, By Region, 2013–2020 (USD Million)
Table 38 Prefilled Autoinjector Devices Market Size, By Region, 2013–2020 (USD Million)
Table 39 Autoinjector Devices Market Size, By Technology, 2013–2020 (USD Million)
Table 40 Automated Autoinjectors Market Size, By Region, 2013–2020 (USD Million)
Table 41 Manual Autoinjectors Market Size, By Region, 2013–2020 (USD Million)
Table 42 Autoinjectors Market Size, By Design, 2013–2020 (USD Million)
Table 43 Standardized Autoinjectors Market Size, By Region, 2013–2020 (USD Million)
Table 44 Customized Autoinjectors Market Size, By Region, 2013–2020 (USD Million)
Table 45 Autoinjectors Market Size, By Usability, 2013–2020 (USD Million)
Table 46 Reusable Autoinjectors Market Size, By Region, 2013–2020 (USD Million)
Table 47 Disposable Autoinjectors Market Size, By Region, 2013–2020 (USD Million)
Table 48 Pen Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 49 Pen Injectors Market Size, By Product, 2013–2020 (USD Million)
Table 50 Single-Chambered Pen Injectors Market Size, By Region,  2013–2020 (USD Million)
Table 51 Dual-Chambered Pen Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 52 Pen Injectors Market Size, By Design, 2013–2020 (USD Million)
Table 53 Standard Pen Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 54 Customized Pen Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 55 Pen Injectors Market Size, By Usability, 2013–2020 (USD Million)
Table 56 Reusable Pen Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 57 Disposable Pen Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 58 Wearable Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 59 Other Devices Market Size, By Region, 2013–2020 (USD Million)
Table 60 Injectable Drug Delivery Formulations Market Size, By Type, 2013–2020 (USD Million)
Table 61 Injectable Drug Delivery Formulations Market Size, By Region, 2013–2020 (USD Million)
Table 62 Conventional Drug Delivery Formulations Market Size, By Type, 2013–2020 (USD Million)
Table 63 Conventional Drug Delivery Formulations Market Size, By Region,  2013–2020 (USD Million)
Table 64 Solutions Market Size, By Region, 2013–2020 (USD Million)
Table 65 Reconstituted/Lyophilized Formulations Market Size, By Region, 2013–2020 (USD Million)
Table 66 Suspensions Market Size, By Region, 2013–2020 (USD Million)
Table 67 Emulsions Market Size, By Region, 2013–2020 (USD Million)
Table 68 Novel Drug Delivery Formulations Market Size, By Type, 2013–2020 (USD Million)
Table 69 Novel Drug Delivery Formulations Market Size, By Region, 2013–2020 (USD Million)
Table 70 Colloidal Dispersion Market Size, By Type, 2013–2020 (USD Million)
Table 71 Colloidal Dispersion Market Size, By Region, 2013–2020 (USD Million)
Table 72 Liposomes Market Size, By Region, 2013–2020 (USD Million)
Table 73 Niosomes Market Size, By Region, 2013–2020 (USD Million)
Table 74 Polymeric/Mixed Micelles Market Size, By Region, 2013–2020 (USD Million)
Table 75 Nanoparticles Market Size, By Type, 2013–2020 (USD Million)
Table 76 Nanoparticles Market Size, By Region, 2013–2020 (USD Million)
Table 77 Nanosuspensions Market Size, By Region, 2013–2020 (USD Million)
Table 78 Nanoemulsions/Microemulsions Market Size, By Region, 2013–2020 (USD Million)
Table 79 Solid-Lipid Nanoparticles Market Size, By Region, 2013–2020 (USD Million)
Table 80 Microparticles Market Size, By Type, 2013–2020 (USD Million)
Table 81 Microparticles Market Size, By Region, 2013–2020 (USD Million)
Table 82 Microspheres Market Size, By Region, 2013–2020 (USD Million)
Table 83 Microcapsules Market Size, By Region, 2013–2020 (USD Million)
Table 84 Long-Acting Injection Formulations Market Size, By Region, 2013–2020 (USD Million)
Table 85 Injectable Drug Delivery Market Size, By Therapeutic Application, 2013–2020 (USD Million)
Table 86 Injectable Drug Delivery Market Size for Autoimmune Diseases, By Indication, 2013–2020 (USD Million)
Table 87 Injectable Drug Delivery Market Size for Autoimmune Diseases Market Size, By Region, 2013–2020 (USD Million)
Table 88 Injectable Drug Delivery Market Size for Rheumatoid Arthritis, By Region, 2013–2020 (USD Million)
Table 89 Injectable Drug Delivery Market Size for Multiple Sclerosis, By Region, 2013–2020 (USD Million)
Table 90 Injectable Drug Delivery Market Size for Crohn’s Disease, By Region, 2013–2020 (USD Million)
Table 91 Injectable Drug Delivery Market Size for Psoriasis, By Region, 2013–2020 (USD Million)
Table 92 Injectable Drug Delivery Market Size for Other Autoimmune Diseases,  By Region, 2013–2020 (USD Million)
Table 93 Injectable Drug Delivery Market Size for Hormonal Disorders, By Indication, 2013–2020 (USD Million)
Table 94 Injectable Drug Delivery Market Size for Hormonal Disorders, By Region, 2013–2020 (USD Million)
Table 95 Injectable Drug Delivery Market Size for Diabetes, By Region, 2013–2020 (USD Million)
Table 96 Injectable Drug Delivery Market Size for Anemia, By Region, 2013–2020 (USD Million)
Table 97 Injectable Drug Delivery Market Size for Reproductive Health Disease, By Region, 2013–2020 (USD Million)
Table 98 Injectable Drug Delivery Market Size for Antithrombotic/Thrombolytic Therapy, By Region, 2013–2020 (USD Million)
Table 99 Injectable Drug Delivery Market Size for Osteoporosis, By Region,  2013-2020 (USD Million)
Table 100 Injectable Drug Delivery Market Size for Growth Hormone Deficiency (GHD), By Region, 2013-2020 (USD Million)
Table 101 Injectable Drug Delivery Market Size for Orphan Diseases, By Region, 2013-2020 (USD Million)
Table 102 Injectable Drug Delivery Market Size for Oncology, By Region, 2013-2020 (USD Million)
Table 103 Injectable Drug Delivery Market Size for Other Therapeutic Applications, By Indication, 2013-2020 (USD Million)
Table 104 Injectable Drug Delivery Market Size for Other Therapeutic Applications,  By Region, 2013-2020 (USD Million)
Table 105 Injectable Drug Delivery Market Size for Pain Management, By Region,  2013-2020 (USD Million)
Table 106 Injectable Drug Delivery Market Size for Allergy Treatment, By Region,  2013-2020 (USD Million)
Table 107 Injectable Drug Delivery Market Size for Aesthetic Treatments, By Region, 2013-2020 (USD Million)
Table 108 Injectable Drug Delivery Market Size for Hepatitis C, By Region, 2013-2020 (USD Million)
Table 109 Injectable Drug Delivery Market Size for Hemophilia, By Region, 2013-2020 (USD Million)
Table 110 Injectable Drug Delivery Market Size, By Usage Pattern, 2013–2020 (USD Million)
Table 111 Curative Care Market Size, By Region, 2013-2020 (USD Million)
Table 112 Immunization Market Size, By Region, 2013-2020 (USD Million)
Table 113 Other Usage Patterns Market Size, By Region, 2013–2020 (USD Million)
Table 114 Injectable Drug Delivery Market Size, By Mode of Administration,  2013—2020 (USD Million)
Table 115 Skin Administration Market Size, By Region, 2013—2020 (USD Million)
Table 116 Circulatory/Musculoskeletal Administration Market Size, By Region,  2013—2020 (USD Million)
Table 117 Organ Administration Market Size, By Region, 2013—2020 (USD Million)
Table 118 Central Nervous System Administration Market Size, By Region, 2013—2020 (USD Million)
Table 119 Injectable Drug Delivery Market Size, By End User, 2013-2020 (USD Million)
Table 120 Injectable Drug Delivery Market Size, By Region, 2013-2020 (USD Million)
Table 121 Hospitals and Clinics Market Size, By Region, 2013-2020 (USD Million)
Table 122 Home Care Settings Market Size, By Region, 2013-2020 (USD Million)
Table 123 Research Laboratories Market Size, By Region, 2013-2020 (USD Million)
Table 124 Pharmaceutical and Biotechnology Companies Market Size, By Region,  2013-2020 (USD Million)
Table 125 Other End Users Market Size, By Region, 2013-2020 (USD Million)
Table 126 Injectable Drug Delivery Market Size, By Region, 2013-2020 (USD Million)
Table 127 North America: Injectable Drug Delivery Market Size, By Country,  2013-2020 (USD Million)
Table 128 North America: Market Size, By Type, 2013–2020 (USD Million)
Table 129 North America: Market Size, By Device, 2013–2020 (USD Million)
Table 130 North America: Market Size, By Formulation,  2013-2020 (USD Million)
Table 131 North America: Market Size, By Therapeutic Application, 2013–2020 (USD Million)
Table 132 North America: Market Size, By Usage Pattern,  2013–2020 (USD Million)
Table 133 North America: Market Size, By Mode of Administration, 2013–2020 (USD Million)
Table 134 North America: Market Size, By End User,  2013–2020 (USD Million)
Table 135 U.S.: Market Size, By Type, 2013–2020 (USD Million)
Table 136 U.S.: Market Size, By Device, 2013–2020 (USD Million)
Table 137 U.S.: Market Size, By Formulation, 2013-2020 (USD Million)
Table 138 U.S.: Market Size, By Therapeutic Application,  2013–2020 (USD Million)
Table 139 U.S.: Market Size, By Usage Pattern, 2013–2020 (USD Million)
Table 140 U.S.: Market Size, By Mode of Administration,  2013–2020 (USD Million)
Table 141 U.S.: Market Size, By End User, 2013–2020 (USD Million)
Table 142 Canada: Market Size, By Type, 2013–2020 (USD Million)
Table 143 Canada: Market Size, By Device, 2013–2020 (USD Million)
Table 144 Canada: Market Size, By Formulation, 2013-2020 (USD Million)
Table 145 Canada: Market Size, By Therapeutic Application, 2013–2020 (USD Million)
Table 146 Canada: Market Size, By Usage Pattern, 2013–2020 (USD Million)
Table 147 Canada: Market Size, By Mode of Administration, 2013–2020 (USD Million)
Table 148 Canada: Market Size, By End User, 2013–2020 (USD Million)
Table 149 Europe: Market Size, By Country, 2013-2020 (USD Million)
Table 150 Europe: Market Size, By Type, 2013–2020 (USD Million)
Table 151 Europe: Market Size, By Device, 2013–2020 (USD Million)
Table 152 Europe: Market Size, By Formulation, 2013-2020 (USD Million)
Table 153 Europe: Market Size, By Therapeutic Application, 2013–2020 (USD Million)
Table 154 Europe: Market Size, By Usage Pattern, 2013–2020 (USD Million)
Table 155 Europe: Market Size, By Mode of Administration, 2013–2020 (USD Million)
Table 156 Europe: Market Size, By End User, 2013–2020 (USD Million)
Table 157 Germany: Market Size, By Type, 2013-2020 (USD Million)
Table 158 Germany: Market Size, By Device, 2013-2020 (USD Million)
Table 159 Germany: Market Size, By Formulation, 2013–2020 (USD Million)
Table 160 Germany: Market Size, By Therapeutic Application, 2013–2020 (USD Million)
Table 161 Germany: Market Size, By Usage Pattern,  2013–2020 (USD Million)
Table 162 Germany: Market Size, By Mode of Administration, 2013–2020 (USD Million)
Table 163 Germany: Market Size, By End User, 2013–2020 (USD Million)
Table 164 France: Market Size, By Type, 2013–2020 (USD Million)
Table 165 France: Market Size, By Device, 2013–2020 (USD Million)
Table 166 France: Market Size, By Formulation, 2013-2020 (USD Million)
Table 167 France: Market Size, By Therapeutic Application, 2013–2020 (USD Million)
Table 168 France: Market Size, By Usage Pattern, 2013–2020 (USD Million)
Table 169 France: Market Size, By Mode of Administration, 2013–2020 (USD Million)
Table 170 France: Market Size, By End User, 2013–2020 (USD Million)
Table 171 U.K.: Market Size, By Type, 2013-2020 (USD Million)
Table 172 U.K.: Market Size, By Device, 2013-2020 (USD Million)
Table 173 U.K.: Market Size, By Formulation, 2013-2020 (USD Million)
Table 174 U.K.: Market Size, By Therapeutic Application,  2013-2020 (USD Million)
Table 175 U.K.: Market Size, By Usage Pattern, 2013–2020 (USD Million)
Table 176 U.K.: Market Size, By Mode of Administration,  2013–2020 (USD Million)
Table 177 U.K.: Market Size, By End User, 2013–2020 (USD Million)
Table 178 Italy: Market Size, By Type, 2013–2020 (USD Million)
Table 179 Italy: Market Size, By Device, 2013–2020 (USD Million)
Table 180 Italy: Market Size, By Formulation, 2013–2020 (USD Million)
Table 181 Italy: Market Size, By Therapeutic Application,  2013–2020 (USD Million)
Table 182 Italy: Market Size, By Usage Pattern, 2013–2020 (USD Million)
Table 183 Italy: Market Size, By Mode of Administration,  2013–2020 (USD Million)
Table 184 Italy: Market Size, By End User, 2013–2020 (USD Million)
Table 185 Spain: Market Size, By Type, 2013–2020 (USD Million)
Table 186 Spain: Market Size, By Device, 2013–2020 (USD Million)
Table 187 Spain: Market Size , By Formulation, 2013-2020 (USD Million)
Table 188 Spain: Market Size, By Therapeutic Application, 2013–2020 (USD Million)
Table 189 Spain: Market Size, By Usage Pattern, 2013–2020 (USD Million)
Table 190 Spain: Market Size, By Mode of Administration, 2013–2020 (USD Million)
Table 191 Spain: Market Size, By End User, 2013–2020 (USD Million)
Table 192 RoE: Market Size, By Type, 2013–2020 (USD Million)
Table 193 RoE: Market Size, By Device, 2013–2020 (USD Million)
Table 194 RoE: Market Size, By Formulation, 2013-2020 (USD Million)
Table 195 RoE: Market Size, By Therapeutic Application,  2013–2020 (USD Million)
Table 196 RoE: Market Size, By Usage Pattern, 2013–2020 (USD Million)
Table 197 RoE: Market Size, By Mode of Administration,  2013–2020 (USD Million)
Table 198 RoE: Market Size, By End User, 2013–2020 (USD Million)
Table 199 Asia: Market Size, By Type, 2013–2020 (USD Million)
Table 200 Asia: Market Size, By Device, 2013–2020 (USD Million)
Table 201 Asia: Market Size, By Formulation, 2013-2020 (USD Million)
Table 202 Asia: Market Size, By Therapeutic Application,  2013–2020 (USD Million)
Table 203 Asia: Market Size, By Usage Pattern, 2013–2020 (USD Million)
Table 204 Asia: Market Size, By Mode of Administration,  2013–2020 (USD Million)
Table 205 Asia: Market Size, By End User, 2013–2020 (USD Million)
Table 206 RoW: Market Size, By Type, 2013–2020 (USD Million)
Table 207 RoW: Market Size, By Device, 2013–2020 (USD Million)
Table 208 RoW: Market Size, By Formulation, 2013-2020 (USD Million)
Table 209 RoW: Market Size, By Therapeutic Application,  2013–2020 (USD Million)
Table 210 RoW: Market Size, By Usage Pattern, 2013–2020 (USD Million)
Table 211 RoW: Market Size, By Mode of Administration, 2013–2020 (USD Million)
Table 212 RoW: Market Size, By End User, 2013–2020 (USD Million)
Table 213 New Product Launches, 2012–2015
Table 214 FDA Approvals, 2012–2015
Table 215 Expansions and Investments, 2012–2015
Table 216 Acquisitions, 2012–2015
Table 217 Collaborations, 2012–2015

List of Figures

Figure 1 Research Design
Figure 2 Market Size Estimation: Bottom-Up Approach
Figure 3 Market Size Estimation: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation,  and Region
Figure 5 Data Triangulation Methodology
Figure 6 Injectable Drug Delivery Market, By Formulation, 2015 vs 2020
Figure 7 Injectable Drug Delivery Market, By Device, 2015 vs 2020
Figure 8 Hospitals and Clinics to Form the Largest End-User Segment
Figure 9 Injectable Drug Delivery Market, By Therapeutic Application, 2015 vs 2020
Figure 10 Injectable Drug Delivery Formulations Market to Grow at the Highest CAGR From 2015 to 2020
Figure 11 The Curative Care Segment to Witness the Highest Growth Rate in the Forecast Period
Figure 12 Skin Segment to Account for the Largest Share in 2015
Figure 13 Hormonal Disorders Segment to Account for the Largest Share in 2015
Figure 14 Asia to Witness Highest Growth Rate During the Forecast Period
Figure 15 Market Segmentation, By Type
Figure 16 Market Segmentation, By Therapeutic Application
Figure 17 Market Segmentation, By Usage Pattern
Figure 18 Market Segmentation, By Mode of Administration
Figure 19 Market Segmentation, By End User
Figure 20 Market Segmentation, By Region
Figure 21 Drivers, Restraints, Opportunities, and Challenges of the Injectable Drug Delivery Market
Figure 22 Injectable Drug Delivery Therapeutic Applications Market, By Region, 2013–2020 (USD Million)
Figure 23 Therapeutic Applications: Oncology to Show Highest Growth During the Forecast Period
Figure 24 Injectable Drug Delivery Market, By Usage Pattern: Curative Care Segment to Hold Largest Share
Figure 25 Injectable Drug Delivery Market, By Mode of Administration: Skin Segment to Show Highest Growth
Figure 26 Market Segmentation, By End User
Figure 27 Injectable Drug Delivery Market, By End User: Hospitals and Clinics to Hold Largest Market Share in 2015
Figure 28 North America to Hold the Largest Share of the Global Market (2015)
Figure 29 European Injectable Drug Delivery Market Snapshot (2015)
Figure 30 RoE: Self-Injection Devices Market Snapshot
Figure 31 Asia to Be the Fastest-Growing Regional Segment of the Global Injectable Drug Delivery Market (2015)
Figure 32 Rising Prevalence of Chronic Diseases to Drive the Growth of the Injectable Drug Delivery Market in the RoW (2015)
Figure 33 New Product Launches, Key Growth Strategy Between 2012 & 2015
Figure 34 Market Share, By Key Player (2014)
Figure 35 Market Evolution Framework: Partnerships, AGreements, and Collaborations & Expansions are Fueling Market Growth
Figure 36 Battle for Market Share: New Product Launches Was the Key Strategy Adopted By Leading Players, 2014
Figure 37 Product Benchmarking for Top 5 Players
Figure 38 Baxter International, Inc.: Company Snapshot
Figure 39 Becton, Dickinson and Company: Company Snapshot
Figure 40 Gerresheimer AG: Company Snapshot
Figure 41 Pfizer, Inc.: Company Snapshot
Figure 42 Schott AG: Company Snapshot
Figure 43 Alkermes PLC: Company Snapshot
Figure 44 ELI Lilly and Company: Company Snapshot
Figure 45 Sandoz: Company Snapshot
Figure 46 Terumo Corporation: Company Snapshot
Figure 47 Teva Pharmaceutical Industries Ltd.: Company Snapshot

  • Overview of Global and Chinese 3D Printing Market 2015-2020
    ‘2015 3D Printing Industry Report -Global and Chinese Market’ is a comprehensive research report that describes the scope of the Global and Chinese 3D printing industry, analyzing the end-users behavior and the latest industry trends. Also, the report evaluates the growth prospects and the up-coming opportunities in the industry over the forecast period of 2015-2020. [...]
  • Schottky Diode Industry Research – 2015 Global and Chinese Market Overview
    ‘2015 Schottky Diode Industry Report – Global and Chinese Market Scenario’ is a top-notch research report, delivering premium industry insights and explanations of complex business scenarios. The report systematically articulates various growth prospects and current market challenges being faced by the existing industry players. The research report also drafts a meticulous business forecast that provides [...]
  • Codeine (CAS 76-57-3) Industry Research Report – 2009-2019 Market Forecast
    ‘Global and Chinese Codeine (CAS 76-57-3) Industry, 2009-2019 Market Research Report’, a systematically structured research report, that aims to deliver a detailed understanding of vivid market scenarios prevalent in the Codeine (CAS 76-57-3) industry to the user.  The report articulates various sections that thoroughly describe all key-aspects of the Codeine (CAS 76-57-3) industry. The report [...]
  • Global and Chinese Mainframe Banking Industry 2015 Outlook
    2015 Banks Mainframe Industry Report -Global and Chinese Market is a detailed market research report, delivering premium industry insights and analyzing the growth prospects of the industry over the forecast period of 2015-2020. The systematically structured sections of the research report, aims at conveying a strong business understanding to the user, enhancing the decision making [...]
  • Global and Chinese Market Situation of Milk Infant Formula Industry Over the Period of 2009-2019
    ‘Market Research Report on Global and Chinese Milk Infant Formula Industry, 2009-2019’ a comprehensive market study, that analyses various market landscape and key-aspects of the industry, delivering premium business insight and thorough understanding of the Global and Chinese market conditions to the user. Industry experts have methodologically structured the elaborative sections of the research report, [...]
    • The Oil Drilling Rig Industry
    • The Oil Drilling Rig Industry is characterized with a few typical work specific to this industry only. The work begins with the search for new oil basins or construction of wells. During this time the services of drilling contractors and se…

    • HER2-Negative Breast Cancer’s Therapeutic Market
    • HER2-Negative Breast Cancer is the most common form of cancer occurring in women. The long term survival of patients diagnosed with HER2-Negative Breast Cancer depends solely on its early detection as till now there is no medicine that can …

    • The Market of Plate Heat Exchanger
    • Plate heat exchanger is not only very useful but its also easy to maintain, its compact design makes it more efficient, the product is highly cost-efficient and also the materials of this product are easily available. There are some limitat…

    • The Industry of Binding Machines
    • Binding of books and papers is one of the most important aspect of buying and selling books and thus the demand of binding machines. There are different kinds of binding machines available in the market. The binding type determines the bind…

    • The Boom In Women Infertility Market
    • Infertility is an abnormality in the regular functioning of the human reproductive system. Anyone of male or female might be suffering from this issue. Infertility in woman is caused by either a genetical factor or factors such as aging or …

  • Oral Drug Delivery Market to 2017 - Out-licensing Proprietary Technologies for Proteins, Peptides and Small Molecules to Drive Revenue Growth
    Published: 30-Apr-2012        Price: US 3500 Onwards        Pages: 68
    GBI Research, the leading business intelligence provider, has released its latest research "Oral Drug Delivery Market to 2017 - Out-licensing Proprietary Technologies for Proteins, Peptides and Small Molecules to Drive Revenue Growth". The report focuses on the current scenario of orally administered drugs. Key segment of orally administered drugs which are covered in the report include small molecules, proteins, peptides and vaccines. The oral drug delivery market is forecast to show increase i......
  • Ireland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018
    Published: 31-Jan-2013        Price: US 2500 Onwards        Pages: 81
    Ireland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018 Summary "Ireland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018", a new report by Global Markets Direct, provides key market data on the Ireland Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 4 market categories - Metered Dose Inhaler Devices, Infusion Systems, Centr......
  • Nanotechnology Drug Delivery Market in the US 2012-2016
    Published: 28-Mar-2013        Price: US 2000 Onwards        Pages: 30
    TechNavio''s analysts forecast the Nanotechnology Drug Delivery market in the US to grow at a CAGR of 84.79 percent over the period 2012-2016. One of the key factors contributing to this market growth is the low R and D cost. The Nanotechnology Drug Delivery market in the US has also been witnessing the trend of emergence of personalized medicines. However, the increasing safety concerns could pose a challenge to the growth of this market. TechNavio''s report, the Nanotechnology Drug Delivery......
  • North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017
    Published: 08-Apr-2013        Price: US 4650 Onwards        Pages: 280
    The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In therap......
  • Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017
    Published: 24-Apr-2013        Price: US 4650 Onwards        Pages: 316
    The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery; the market is forecast till 2017. Over the years, drug delivery technologies have grown phenomenally from plain drug reformulation and release technologies to innovative platforms that hold a huge potential for the effective delivery of biologicals and novel drugs. The glob......
  • European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017
    Published: 24-Jun-2013        Price: US 4650 Onwards        Pages: 300
    The European drug delivery market was worth $39.9 billion in the year 2012. The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery. Over the years, drug delivery technologies have grown phenomenally from plain drug reformulation and release technologies, to innovative platforms that hold a huge potential for the effective delivery ......
  • Global Pulmonary Drug Delivery Systems Market 2012-2016
    Published: 01-Jul-2013        Price: US 2000 Onwards        Pages: 48
    TechNavio's analysts forecast the Global Pulmonary Drug Delivery Systems market to grow at a CAGR of 14.47 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing incidence of lung-related or respiratory diseases. The Global Pulmonary Drug Delivery Systems market has also been witnessing an increasing adoption of online marketing strategy. However, intense competition among vendors could pose a challenge to the growth of this market. ......
  • U.S. and European Markets for Nebulizers - 2013
    Published: 01-Sep-2013        Price: US 6995 Onwards        Pages: 69
    The U.S. and European Markets for Nebulizers includes stationary compressor/jet nebulizers, portable compressor/jet nebulizers, ultrasonic nebulizers and vibrating mesh nebulizers. In the U.S. portable compressor and vibrating mesh nebulizers will see appreciable upswings in market value due to increasing consumer awareness of the benefits of delivery systems using nebulization technology. The total European Nebulizer market will continue to experience growth in overall unit sales of nebul......
  • MediPoint: Drug-Eluting Balloons - US Analysis and Market Forecasts
    Published: 30-Sep-2013        Price: US 4450 Onwards        Pages: 377
    GlobalData has released its medical devices report, "MediPoint: Drug-Eluting Balloons US Analysis and Market Forecasts". The report is an essential source of information and analysis on the drug-eluting balloons (DEB) market in the US. The report provides in-depth insight into the use of DEB for coronary and peripheral applications in the lower extremity including in-stent restenosis, bifurcation lesions, small vessel disease, femoropopliteal artery and below-the-knee lesions, chronic total occl......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs